Insomnia is a common problem that is highly prevalent among people with mental health disorders. The treatment of insomnia often is challenging due to the multiple influences that can undermine sleep quality and quantity. Dr. Neubauer will briefly review the problem of insomnia and provide an overview of therapeutic approaches. The primary focus of this session will be targeted pharmacologic approaches that address specific patient populations and symptoms complexes. The consideration of medications for insomnia should include both pharmacokinetic and pharmacodynamic properties. In this way, pharmacotherapy can be customized for individual patients.
